Search - tctmd.com

Displaying 41 - 60 of 63

Sort: Relevancy | Date

News Conference News ACC 2015

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Todd Neale

March 15, 2015

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

Presentation ACC 2014

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease

Presenter: Darren Mylotte

March 30, 2014

News Conference News ACC 2014

TAV-in-BAV: TAVR Achieves Positive Outcomes In Bicuspid Aortic Valve Disease

Jason Kahn

March 30, 2014

News Conference News ACC 2014

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Yael L. Maxwell

March 29, 2014

News Conference News ACC 2014

Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR

L.A. McKeown

March 29, 2014

Presentation ACC 2013

Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Presenter: Vinod H. Thourani

March 11, 2013

Presentation ACC 2013

The Repositionable Lotus Aortic Valve Replacement System: Six-Month Outcomes in the REPRISE I Feasibility Study

Presenter: Ian T. Meredith

March 11, 2013

Presentation ACC 2013

New Data from the PARTNER Non-Randomized Continued Access Registry: Outcomes After Transfemoral Transcatheter Aortic Valve Replacement

Presenter: William F. Fearon

March 11, 2013

Presentation ACC 2013

Impact of Sex on Outcomes Following Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Insights From The PARTNER Experience

Presenter: Ajay J. Kirtane

March 11, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

L.A. McKeown

March 11, 2013

Presentation ACC 2013

Paravalvular Leaks Post-Transcatheter Aortic Valve Replacement

Presenter: Philippe Généreux

March 09, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

News Conference News ACC 2012

Study Looks at Long-term Mortality Predictors in TAVR Patients

Jason Kahn

March 27, 2012

Presentation ACC 2012

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

Presenter: Susheel K. Kodali

March 26, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

News Conference News ACC 2012

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

March 24, 2012

Video

» Interview

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

May 4, 2022

Advertisement

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease

TAV-in-BAV: TAVR Achieves Positive Outcomes In Bicuspid Aortic Valve Disease

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR

Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

The Repositionable Lotus Aortic Valve Replacement System: Six-Month Outcomes in the REPRISE I Feasibility Study

New Data from the PARTNER Non-Randomized Continued Access Registry: Outcomes After Transfemoral Transcatheter Aortic Valve Replacement

Impact of Sex on Outcomes Following Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Insights From The PARTNER Experience

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

Paravalvular Leaks Post-Transcatheter Aortic Valve Replacement

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Study Looks at Long-term Mortality Predictors in TAVR Patients

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content